Knowledge Tree
Relations (1)
related 4.25 — strongly supporting 18 facts
Psilocybin and Lysergic Acid Diethylamide (LSD) are both classified as classic serotonergic psychedelics that act on the 5-HT2A receptor [1] and are frequently studied together for their shared antidepressive, anxiolytic, and consciousness-altering effects {fact:2, fact:12}. Clinical research and virtual simulations consistently compare these substances to evaluate their impact on brain dynamics, neural fingerprints, and therapeutic potential {fact:4, fact:7, fact:10, fact:13}.
Facts (18)
Sources
A virtual clinical trial of psychedelics to treat patients with disorders ... eurekalert.org 5 facts
referenceAlnagger et al. published a study in the journal Advanced Science that utilized personalized computational models of patients' brains, constructed from individual functional MRI and diffusion-weighted imaging scans, to virtually simulate the effects of LSD and psilocybin on patients with disorders of consciousness.
claimThe simulation of LSD and psilocybin on patients with disorders of consciousness boosted the patients' responses to perturbations.
claimIn healthy volunteers, psychedelic drugs like psilocybin and LSD produce intense, consciousness-altering effects that are thought to be linked with increased dynamical complexity of brain activity.
claimResearchers from the University of Liège and international collaborators developed a virtual clinical trial to explore the use of psychedelic drugs, specifically psilocybin and lysergic acid diethylamide (LSD), as a treatment for patients who do not fully regain consciousness after a coma.
claimThe virtual clinical trial conducted by Alnagger et al. demonstrated that LSD and psilocybin could shift brain activity in patients with disorders of consciousness towards healthier, more flexible, and complex dynamics.
Psychedelics and Consciousness: Distinctions, Demarcations, and ... ouci.dntb.gov.ua 4 facts
measurementMedium and high doses of LSD yield significantly higher ratings of visionary restructuralisation than psilocybin on the 5-dimensional Altered States of Consciousness Scale.
claimRoland Griffiths conducted a survey comparing naturally occurring 'God encounter experiences' with those occasioned by classic psychedelics including psilocybin, LSD, ayahuasca, or DMT.
claimThe literature regarding neural fingerprints of DMT, LSD, and psilocybin is characterized by high heterogeneity and a risk of bias, creating an urgent need for standardized experimental procedures and analysis techniques.
claimMeta-analyses link DMT, LSD, and psilocybin to specific neural fingerprints at each level of analysis, revealing a highly non-linear relationship between these fingerprints.
Classification Schemes of Altered States of Consciousness - ORBi orbi.uliege.be 4 facts
claimSchartner et al. (2017) reported that psychoactive doses of ketamine, LSD, and psilocybin lead to increased spontaneous MEG (magnetoencephalography) signal diversity.
referenceLey et al. (2023) conducted a randomized, double-blind, placebo-controlled cross-over study published in Neuropsychopharmacology comparing the acute effects of mescaline, LSD, and psilocybin in healthy participants.
referenceHolze et al. (2022) conducted a double-blind, placebo-controlled study directly comparing the acute effects of lysergic acid diethylamide (LSD) and psilocybin in healthy subjects, published in Neuropsychopharmacology.
referenceStocker, K., Hartmann, M., Ley, L., Becker, A.M., Holze, F., and Liechti, M.E. (2024) revived the psychedelic experience scale to reveal the extended-mystical, visual, and distressing experiential spectrum associated with LSD and psilocybin.
Psychedelics, Sociality, and Human Evolution frontiersin.org 2 facts
claimA 2016 systematic review of clinical trials published in the previous 25 years found that ayahuasca, psilocybin, and lysergic acid diethylamide (LSD) demonstrate antidepressive, anxiolytic, and antiaddictive effects.
claimPsychedelics such as psilocybin and lysergic acid diethylamide (LSD) modify fundamental brain processes that constrain neural systems central to perception, emotion, cognition, and sense of self.
Neuroimaging in psychedelic drug development: past, present, and ... nature.com 1 fact
claimClassic serotonergic psychedelics, such as psilocybin and lysergic acid diethylamide (LSD), primarily act on the 5-HT2A receptor.
Psychedelics Assessed In New Virtual Clinical Trial - EMJ emjreviews.com 1 fact
claimIn patients with disorders of consciousness, the simulated use of LSD and psilocybin shifted brain activity towards more flexible and complex dynamics.
DRUGS, RITUALS AND ALTERED STATES OF CONSCIOUSNESS semanticscholar.org 1 fact
referenceThe 2022 publication Frontiers in Psychology discusses psychotherapy involving the use of psychedelic substances, specifically identifying psilocybin, lysergic acid diethylamide (LSD), and ketamine as examples.